Patent Filing
Evaluation of vagus nerve stimulation using heart rate variability analysis
Livanova Usa, Inc.5/14/2024·05/14/24🌐 USA
Summary
This patent describes methods for evaluating vagus nerve stimulation therapy effectiveness by analyzing heart rate variability. The implantable VNS system measures ECG data to assess autonomic nervous system responses to stimulation, providing objective feedback for therapy optimization.
Why it matters
Objective therapy evaluation is critical for optimizing VNS treatment, as patient-reported outcomes may not capture subtle therapeutic effects. This technology enables LivaNova's VNS Therapy System to automatically assess and optimize stimulation parameters based on physiological biomarkers, improving therapy personalization and outcomes.
#Closed-Loop#Neurostimulation#Epilepsy#Biomarkers#Bioelectronic Medicine#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in